Aclarion, Inc.
corporate_fare Company Profile
Aclarion, Inc. (NASDAQ:ACON) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 26 items for ACON at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-18, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for ACON spans 4, 10-Q, 8-K, DEF 14A.
Recent high-impact activity:
- CFO Gregory Gould Buys $24,500 of Aclarion Stock at $2.45
- Director Ryan Bond Buys $50K of Aclarion Stock at $2.37
- Aclarion's Q2 Loss Deepens to $2.75M, but $10.4M Raise Pushes Cash Runway into H2 2027
- Aclarion Partners with PRIA Healthcare to Accelerate Nociscan Reimbursement, US Commercial Adoption
- Aclarion Rejects Echo Lake Capital's $4.00/Share Acquisition Offer
Financial Snapshot
Short Interest & Short Volume
1.94 days to coverFINRA reported short interest of 76,007 shares in ACON as of the September 15, 2026 settlement, a 206.9% increase from the prior period — about 1.9 days to cover at its recent average daily volume. On October 2, 2026, 28.8% of ACON volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.